trending Market Intelligence /marketintelligence/en/news-insights/trending/ukjkiocyzm6htkqhlxojbg2 content esgSubNav
In This List

Integra LifeSciences plans common stock offering to reduce debt

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Integra LifeSciences plans common stock offering to reduce debt

Integra LifeSciences Holdings Corp. is planning a public offering of 5,250,000 common shares.

The Plainsboro, N.J.-based surgical implant maker intends to grant the underwriters a 30-day option to buy an additional 787,500 common shares.

Integra plans to use net proceeds to buy additional shares, to cut outstanding revolving borrowings under its senior credit facility.

J.P. Morgan and Wells Fargo Securities will be joint book-running managers for the offering.